Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: IndiaNivesh Securities Pvt Ltd
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

J B Chemicals and Pharmaceuticals Ltd Announces US FDA Approval For Tinidazole


Tuesday, 22 Oct 2013 12:10am EDT 

J B Chemicals and Pharmaceuticals Ltd announced that the receipt of US FDA Approval to its Abbreviated New Drug Application (ANDA) for Tinidazole (for treatment of bacterial infection) 250 mg. and 500 mg. tablets. The company plans to launch this prescription product in Q4 this year. The Company would manufacture these formulations at manufacturing facility at Panoli (Gujarat). 

Latest Developments for J B Chemicals and Pharmaceuticals Ltd

Company Quote

196.75
-3.35 -1.67%
26 Dec 2014